On the other hand, autoantibodies such as anti-MMP-1, anti-MMP-3, and anti-fibrin bound tPA antibodies have been identified in SSc patients, and TIMPs are elevated in SSc [58,72,73,74,75,76], and these factors suppress ECM degradation. This evidence concerns the gene PLAT and systemic sclerosis.